Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
M. Álvaro Berbís(Hospital San Juan de Dios), Jeanne Shen(Stanford University), David S. McClintock(Mayo Clinic in Arizona), Brett Delahunt(Malaghan Institute of Medical Research), Catarina Eloy(Universidade do Porto), Liron Pantanowitz(University of Pittsburgh Medical Center), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Víctor Sánchez-Turrión(Hospital Universitario Puerta de Hierro Majadahonda), José Aneiros‐Fernández(Instituto de Investigación Biosanitaria de Granada), Jerome Cheng(Michigan Cancer Research Consortium), Andrey Bychkov(Kameda Medical Center), Antonio Luna, J. Mark Tuthill(Henry Ford Hospital), Raimundo García del Moral, Eva Hollemans(Erasmus MC), Jochen K. Lennerz(Addgene), Bethany Williams(University of Leeds), Alton B. Farris, Mark Kriegsmann(CS Diagnostics), Markus D. Herrmann(Roche (Switzerland)), Filippo Fraggetta, Lars Egevad(Karolinska Institutet), Jeroen van der Laak(Radboud University Nijmegen), John H. Sinard(Yale University), Aly Karsan(University of British Columbia), Kenneth A. Iczkowski(University of California, Davis), C. Casado Sánchez(Hospital Universitario La Paz), Douglas J. Hartman(University of Pittsburgh)
Cited by 106
Related Papers
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
|JAMA|2017|3.3k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
Classification of renal cell carcinoma
|Cancer|1997|878
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Data-analysis strategies for image-based cell profiling
|Nature Methods|2017|789